Home › Funds › APIS CAPITAL ADVISORS, LLC › ANAB
APIS CAPITAL ADVISORS, LLC position in ANAB
ANAPTYSBIO INC · Health Care
APIS CAPITAL ADVISORS, LLC reported holding 444,000 shares of ANAB (ANAPTYSBIO INC) in its Q3 2026 13F filing — a position valued at US$22.3M, representing 3.15% of its reported portfolio and ranking #12 among its reported holdings. APIS CAPITAL ADVISORS, LLC has disclosed ANAB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How APIS CAPITAL ADVISORS, LLC's ANAB position evolved
APIS CAPITAL ADVISORS, LLC first disclosed a stake in ANAB in Q1 2026 at 238,000 shares (US$13.2M). The position peaked in Q2 2026 at 497,000 shares, worth US$33.5M. Across 3 filings, APIS CAPITAL ADVISORS, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 444,000 shares valued at US$22.3M — a reduction of -53,000 shares quarter over quarter.. Notable position changes include a 109% increase in Q2 2026 (shares fell 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 238.00K | $13.20M | New |
| Q2 2026 | 497.00K | $33.55M | Add |
| Q3 2026 | 444.00K | $22.32M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANAB and 13F data
ANAB (ANAPTYSBIO INC) is a Health Care company. 37 other funds we track also report a position in ANAB — the largest reported positions include EcoR1 Capital, LLC (US$531.9M), TANG CAPITAL MANAGEMENT LLC (US$89.8M), 683 Capital Management, LLC (US$44.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANAB
- EcoR1 Capital, LLC 7.88M sh · $531.91M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.33M sh · $89.83M · Q2 2026
- 683 Capital Management, LLC 660.00K sh · $44.55M · Q2 2026
- Sanofi 821.92K sh · $41.31M · Q3 2026
- Palo Alto Investors LP 603.49K sh · $40.74M · Q2 2026
- First Light Asset Management, LLC 582.00K sh · $39.29M · Q2 2026
- Sofinnova Investments, Inc. 493.54K sh · $33.31M · Q2 2026
- Pertento Partners LLP 545.00K sh · $27.39M · Q3 2026
- Coppell Advisory Solutions LLC 3.64K sh · $16.58M · Q2 2026
More on APIS CAPITAL ADVISORS, LLC
FAQ
How long has APIS CAPITAL ADVISORS, LLC held ANAB?
APIS CAPITAL ADVISORS, LLC has disclosed ANAB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is APIS CAPITAL ADVISORS, LLC's current position in ANAB?
As of Q3 2026, APIS CAPITAL ADVISORS, LLC holds 444.00K shares of ANAB (ANAPTYSBIO INC), valued at $22.32M, representing 3.15% of its reported portfolio and ranking #12.
Has APIS CAPITAL ADVISORS, LLC been buying or selling ANAB?
In the latest 13F filing (Q3 2026), APIS CAPITAL ADVISORS, LLC reduced its position in ANAB. The position peaked in Q2 2026 at 497.00K shares.
Which other funds hold ANAB?
Other major institutional holders of ANAB include EcoR1 Capital, LLC, TANG CAPITAL MANAGEMENT LLC, 683 Capital Management, LLC, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.